DeepMed Research

ALLERGAN AUSTRALIA PTY LIMITED

🇦🇺Australia

Country: 🇦🇺Australia

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Evaluation of Eflornithine on Facial and Forearm Skin

Phase 4

Completed

Conditions: Hirsutism

First Posted Date: 2005-09-09

Last Posted Date: 2019-10-30

Lead Sponsor: Allergan

Target Recruit Count: 78

Registration Number: NCT00152048

A Phase 3 Study to Compare the Safety and Efficacy of 5% Dapsone Topical Gel, (DTG) Twice Daily in Combination With Once Daily Vehicle Control, Adapalene Gel 0.1% or Benzoyl Peroxide Gel 4%

Phase 3

Completed

Conditions: Acne Vulgaris

First Posted Date: 2005-09-09

Last Posted Date: 2011-05-30

Lead Sponsor: Allergan

Target Recruit Count: 301

Registration Number: NCT00151541

Memantine in Patients With Chronic Glaucoma

Phase 3

Completed

Conditions: Open-Angle Glaucoma

First Posted Date: 2005-09-02

Last Posted Date: 2010-11-04

Lead Sponsor: Allergan

Target Recruit Count: 1119

Registration Number: NCT00141882

Safety Study of Botulinum Toxin Type A in Post-Upper Limb Stroke Patients With Reduced Lung Function

Phase 2

Completed

Conditions: Stroke
Muscle Spasticity
Motor Neuron Disease

Interventions: Biological: botulinum toxin Type A
Drug: saline

First Posted Date: 2004-02-26

Last Posted Date: 2011-10-03

Lead Sponsor: Allergan

Target Recruit Count: 155

Registration Number: NCT00076687

Research Study in Patients With Persistent Macular Edema

Phase 2

Completed

Conditions: Diabetes
Macular Edema
Diabetic Retinopathy
Retinal Disease
Uveitis, Posterior

First Posted Date: 2002-05-07

Last Posted Date: 2011-05-30

Lead Sponsor: Allergan

Target Recruit Count: 315

Registration Number: NCT00035906

Locations: 🇺🇸
Oculex Pharmaceuticals, Sunnyvale, California, United States

Six Month Clinical Research Study for Patients With Moderate or Severe Dry Eye Syndrome

Phase 3

Completed

Conditions: Keratoconjunctivitis Sicca
Sjogren's Syndrome
Lupus Erythematosus, Systemic
Arthritis, Rheumatoid
Scleroderma, Systemic

First Posted Date: 2001-10-29

Last Posted Date: 2011-05-30

Lead Sponsor: Allergan

Target Recruit Count: 290

Registration Number: NCT00025818

Locations: 🇺🇸
UCLA, Los Angeles, California, United States
🇺🇸
Indiana University, Indianapolis, Indiana, United States
🇺🇸
Eyecare of La Jolla, La Jolla, California, United States

and more 14 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy